
|Articles|May 4, 2021
The Future of Contract Manufacturing
Author(s)Adare Pharma Solutions
As the industry—and the world—faces unprecedented challenges, your choice of CDMO plays an increasingly important role in the success of your project. New formulations and underserved patient populations demand a level of expertise many development and manufacturing partners simply don’t have. Is your CDMO partner able to adapt to today’s ever-changing world? Giovanni Ortenzi, the leader of Adare Pharma’s global pharmaceutical development and technical services, was recently interviewed about how Adare is uniquely qualified to meet and overcome these new challenges. Adare’s unique mix of expertise, innovation, and capacity makes us the perfect choice to bring your new project to market.
Trending on Pharmaceutical Technology
1
Ask the Expert: Complying with Standards
2
GSDIa Gene Therapy Approval Signals New Path for Rare Disease Manufacturing
3
How the Nitrosamine Guidance Shift is Changing LC-MS Workflows for APIs and Peptides
4
Q&A: Why Sponsors Are Turning to Mixed FSP/FSO Models
5